费索利内坦:一种新型非激素治疗因更年期而导致的血管运动症状的新疗法
Megan Z Roberts1,2, Miranda R Andrus1,2
1Department of Pharmacy Practice, Auburn University Harrison College of Pharmacy, Huntsville, AL, USA.
费索利内坦特有效地降低了与更年期相关的血管运动症状,为激素治疗提供了一个安全的替代方案. 临床试验显示显著的症状减少与最小的不良事件,如头痛.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
- 绝经研究 绝经研究
背景情况:
- 绝经期间血管运动症状很常见,影响生活质量.
- 荷尔蒙疗法对一些女性有安全问题或禁忌.
- 费索利尼坦针对绝经相关的血管运动症状的病理生理学.
研究的目的:
- 审查fezolinetant的药理学,药理动力学和药理动力学数据.
- 总结来自临床试验的疗效和安全数据.
- 识别正在进行的研究和数据缺口.
主要方法:
- 在PubMed和EMBASE数据库中进行文献搜索.
- 对有关fezolinetant有效性和安全性的同行评审出版物的审查.
- 在clinicaltrials.gov.gov中对注册试验的评估.
主要成果:
- 与安慰剂相比,Fezolinetant显著降低了血管运动症状的频率和严重程度.
- 报告的最常见的不良事件是头痛 (5-10%).
- 在审查的研究中没有发现严重的安全信号.
结论:
- 费索利内坦是适度至严重的血管运动症状的有效非激素治疗方法.
- 需要进一步的研究来进行对比和长期的安全性/有效性数据.
- 对于那些无法使用或不愿意使用激素治疗的患者来说,Fezolinetant是一个可行的替代品.
更多相关视频
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
04:35Author Spotlight: Demonstrating Therapeutic Effect of Automated Zhuang Medicine Line Moxibustion Simulator
Published on: January 19, 2024
相关概念视频
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antidepressant Drugs: MAOIs and Other Agents
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
